Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 54 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.
    Yu Lu, Xin Cai, Yanhui Li +11
    TheranosticsPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Benchmarking the Intratumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Longitudinal Assessment of Contamination Sources and Decontamination Strategies
    L. Dang, L. Eskelson, J. Hamm +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. WITHDRAWN: Atypical MDM2 p53 Regulation and Chemosensitivity Induced by Proximal PAS Deletion
    M. Kim, C. Yoon, J. Jun +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. BfBio: a graph-based tool for the prediction of Angiogenic Stalk Cell genes using a Personalized PageRank algorithm
    L. Bettoni, J. Dmitrieva, M. Mousa +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Dual-oxygen pancreatic cancer organoids recapitulate basal–classical heterogeneity validated by spatial transcriptomics
    Koichiro Kumano, Hiromitsu Nakahashi, Osamu Shimomura +17
    British Journal of CancerPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  6. Clinical and endoscopic features of checkpoint inhibitor–induced colitis and their association with selective immunosuppressive therapy use
    Myrthe R Naber, Mick J M van Eijs, Jildou S Huitema +4
    Inflammatory Bowel DiseasesPeer-reviewedCC BY 4.0Full text2 citedOncologyPMC
  7. Investigating the role of costimulatory domains in enhancing CAR-T cell persistence in TNBC
    Hany E. Marei, Giacomo Pozzoli, Carlo Cenciarelli
    Cancer Gene TherapyPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  8. Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
    Jinyong Kim, Sehhoon Park, Gyeong-Won Lee +16
    JTO clinical and research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  9. Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study
    Jinyong Kim, MD, PhD, Sehhoon Park, MD, PhD, Gyeong-Won Lee, MD, PhD +16
    JTO Clinical and Research ReportsPeer-reviewedCC BY-NC-NDFull textOncologyDOAJEurope PMCPMC
  10. Leptin receptor deficiency suppresses gastric tumorigenesis by limiting stromal activation and tumor microenvironment development.
    K. Inagaki-Ohara, D. Motooka, I. Yamanaka +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  11. PSEN1 Expression Identifies a Developmentally Distinct Favorable-Prognosis State in SHH α Medulloblastoma
    J. Vanini, A. Thomaz, M. M. Lupatini +4
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  12. Activity and specificity of KRAS variants-directed Revolution Medicines Company (RMC) compounds for pleural effusion-derived non-small cell lung cancer cell lines
    Sandra Stickler, Marie-Therese Eggerstorfer, Maximilian Rieche +5
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  13. CD39+CD103+CD8+ T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma
    Suling Chen, Yupeng Wu, Guangxin Rao +16
    British Journal of CancerPeer-reviewedLicence not statedFull textOncologyPMC
  14. The ferroptosis inhibitor NUPR1 coordinates the mitochondrial response to oxidative stress and cell metabolism during COPD pathogenesis in the lung
    Jessica Nouws, Saul S. Siller, Tao Yang +7
    American journal of physiology. Lung cellular and molecular physiologyPeer-reviewedCC BYFull text2 citedOncologyPMC
  15. Comparison of a Novel Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Colon Cancer: A Propensity Score–Weighted, Prospective Idea, Development, Exploration, Assessment, Long-term Stage 2b Cohort Study
    Qiang Du, Tian Wei, Libin Huang +3
    Diseases of the Colon and RectumPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Deep mapping of structural perturbations to energetics enables precise TCR design
    Shifu Luo, Songming Zhang, Ying Shi +5
    Cell Reports MethodsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  17. Pheno-MYCN maps the morphological footprint of MYCN amplification in paediatric neuroblastoma
    B. Chai, O. Fourkioti, R. Naidoo +7
    bioRxivPreprintCC BYFull textOncologybioRxiv
  18. Multimodal spatial-omics reveal the heterogeneity and intercellular network characteristics of papillary craniopharyngiomas.
    Y. Jiang, H. Luo, H. Zheng +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  19. Crosstalk between S-nitrosylation and glycation defines a metabolic vulnerability in liver and renal cancers
    Chiara Pecorari, Mojca Bratina, Evelyn Gonzalez +22
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyHAL
  20. Clinical Features and Predictors of Hospital Stay in Paediatric Epstein–Barr Virus Infectious Mononucleosis: A Multicentre Cohort Study
    Lasse H. Nyhegn, Sara Yde Steffensen, Sabine Frølich Maarbjerg +3
    Acta Paediatrica (Oslo, Norway : 1992)Peer-reviewedCC BY-NC 4.0Full text1 citedOncologyPMC
  21. Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation
    Kaikai Xu, Lulu Kong, Kebin Ye +7
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  22. Kdm2a histone demethylase ablation restores anti-tumor immunogenicity in liver cancer
    Laura Gragnani, Matteo Lulli, Patrizio Caini +9
    British Journal of CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Restoring skeletal remodeling in antiresorptive-treated patients: clinical outcomes of teriparatide in medication-related osteonecrosis of the jaw
    Ana Karina Sarmiento Liévano, Hannah Vanessa Ceballos Sarmiento, Nicolás Jiménez Vega +2
    Osteoporosis InternationalPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  24. Neoadjuvant Chemotherapy Increases Genomic Radioresistance in Hormone Receptor–positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Implications for Radiation Sensitivity Index/Genomic-Adjusted Radiation Dose–Guided Radiation Therapy Personalization
    Pierre Loap, Gilles Crehange, Youlia Kirova
    Advances in Radiation OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMC
  25. The Role of VEGF-C and VEGF-D in Coronary Artery Disease: From Molecular Pathophysiology to Therapeutic Lymphangiogenesis
    Hiromichi Wada, Kazuhiko Kotani, Moritake Iguchi +1
    Journal of Atherosclerosis and ThrombosisPeer-reviewedCC BY-NC-SA 4.0Full textOncologyJ-STAGEPMC